Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors
Blokhin's Russian Cancer Research Center
Blokhin's Russian Cancer Research Center
Qilu Pharmaceutical Co., Ltd.
Fudan University
National Cancer Centre, Singapore
Shanghai Zhongshan Hospital
Delcath Systems Inc.
Hebei Medical University Fourth Hospital
Taizhou Hanzhong biomedical co. LTD
Air Force Military Medical University, China
ChineseAMS
Velindre NHS Trust
Guangdong Association of Clinical Trials
Shandong Cancer Hospital and Institute
Medical Research Council
Seoul National University Bundang Hospital
Air Force Military Medical University, China
Sun Yat-sen University
Wales Cancer Trials Unit
Nihon University
European Organisation for Research and Treatment of Cancer - EORTC